10
Oct
2023

RWE over the lifecycle of ATMPs to meet the HTA (Regulation) Needs

Under the EU Health Technology Assessment Regulation (HTAR), oncology medicines and Advanced Therapeutic Medicinal Products (ATMPs) will be the first to undergo Joint Clinical Assessments, starting in January 2025. As there is often a paucity of clinical evidence available for these highly innovative treatments, the 2023 RWE4Decisions webinar series will consider the potential for use of Real-World Data (RWD), given there is no EU-wide guidance on Real-World Evidence (RWE) generation or use.

Join us on 10 October for the RWE4Decisions webinar on how RWE over the lifecycle of ATMPs could support the EU joint HTA work. You will hear from Prof Ana Hidalgo-Simon, who will set the scene on the clinical and regulatory context for ATMPs in the EU. A multi-stakeholder panel will then follow, representing the voices of HTA bodies, payers, patients and industry, on the opportunities and challenges with RWE generation and assessment for ATMPs.

x

PROGRAMME

x

15:00

Welcome from the co-moderators (RWE4Decisions Steering Group)

  • Eric Sutherland
    Senior Health Economist, Organisation for Economic Co-operation and Development (OECD)
    Karen Facey
    RWE4Decisions Facilitator
15:10

Keynote Presentation

  • Ana Hidalgo-Simon
    Associate Professor, Leiden University Medical Center
15:25

Panel Discussion

  • Niklas Hedberg
    Chief Pharmacist, Swedish Dental and Pharmaceuticals Benefits Agency (TLV), RWE4Decisions Steering Group Member
  • Christoph Rupprecht
    Head of Department Health Policy & Health Economics, Allgemeine Ortskrankenkasse (AoK)
  • Simone Boselli
    Public Affairs Director, EURORDIS-Rare Diseases Europe, RWE4Decisions Steering Group Member
  • Alexander Natz
    Secretary General, European Confederation of Pharmaceutical Entrepreneurs (EUCOPE), RWE4Decisions Steering Group Member
16:20

Closing remarks by the co-moderators

  • Eric Sutherland
    Senior Health Economist, Organisation for Economic Co-operation and Development (OECD)
    Karen Facey
    RWE4Decisions Facilitator
16:30

Meeting close


Upcoming Events

More
23
Oct
2024
Public Webinar: HTA/Payer National Collaborative Initiatives – The Role of Real-World Evidence
15:00-16:00 CEST
Online
14
Nov
2024
RWE4Decisions Symposium: Developing Real-World Evidence to Deliver Innovation in HTA
09:00-13:00 CET
Hybrid, Brussels